Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes. An Exploratory Analysis From the RELAX-AHF Trial

JACC: Heart Failure

Volumn 4, Issue 7, 2016, Pages 591-599

  Pang, Peter S ^a   Teerlink, John R ^b,l   Voors, Adriaan A ^c   Ponikowski, Piotr ^d   Greenberg, Barry H ^e   Filippatos, Gerasimos ^f   Felker, G Michael ^g   Davison, Beth A ^h   Cotter, Gad ^h   Kriger, Joshua ⁱ   Prescott, Margaret F ^j   Hua, Tsushung A ^j   Severin, Thomas ^j   Metra, Marco ^k  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d WROCLAW MEDICAL UNIVERSITY   (Poland)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Momentum Research Inc   (United States)

ⁱ Och Spine at New York Presbyterian Hospitals   (United States)

^j NOVARTIS PHARMA AG   (Switzerland)

^k UNIVERSITY OF BRESCIA   (Italy)

^l SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

Acute heart failure; Emergency department; Risk stratification; Serelaxin

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NITRIC ACID DERIVATIVE; PLACEBO; SERELAXIN; TROPONIN T; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); RECOMBINANT PROTEIN; RELAXIN; SERELAXIN PROTEIN, HUMAN;

ACUTE HEART FAILURE; AGED; ARTICLE; CONFIDENCE INTERVAL; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EXPLORATORY RESEARCH; FEMALE; HAZARD RATIO; HEART DEATH; HEART MUSCLE INJURY; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LENGTH OF STAY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; UNIVARIATE ANALYSIS; ACUTE DISEASE; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COMORBIDITY; HEART FAILURE; HOSPITAL EMERGENCY SERVICE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COMORBIDITY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PATIENT READMISSION; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; RELAXIN; RENAL INSUFFICIENCY; RISK ASSESSMENT; TREATMENT OUTCOME; TROPONIN T;

EID: 84962074467     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2016.02.009     Document Type: Article

References (36)

1. O'Connor C.M., Hasselblad V., Mehta R.H., et al. Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. J Am Coll Cardiol 2010, 55:872-878.
2. Zaya M., Phan A., Schwarz E.R. Predictors of re-hospitalization in patients with chronic heart failure. World J Cardiol 2012, 4:23-30.
3. Lee D.S., Austin P.C., Rouleau J.L., Liu P.P., Naimark D., Tu J.V. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. Jama 2003, 290:2581-2587.
4. Collins S.P., Storrow A.B. Moving toward comprehensive acute heart failure risk assessment in the emergency department: the importance of self-care and shared decision making. J Am Coll Cardiol HF 2013, 1:273-280.
5. Schuur J.D., Venkatesh A.K. The growing role of emergency departments in hospital admissions. N Engl J Med 2012, 367:391-393.
6. Pang P.S., Schuur J.D. Emergency departments, acute heart failure, and admissions: one size does not fit all. J Am Coll Cardiol HF 2014, 2:278-280.
7. Adams K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005, 149:209-216.
8. Collins S., Storrow A.B., Albert N.M., et al. Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for Academic Emergency Medicine/Heart Failure Society of America Acute Heart Failure Working Group. J Card Fail 2015, 21:27-43.
9. Collins S.P., Lindsell C.J., Jenkins C.A., et al. Risk stratification in acute heart failure: rationale and design of the STRATIFY and DECIDE studies. Am Heart J 2012, 164:825-834.
10. Pang P.S., Jesse R., Collins S.P., Maisel A. Patients with acute heart failure in the emergency department: do they all need to be admitted?. J Card Fail 2012, 18:900-903.
11. Collins S.P., Pang P.S., Fonarow G.C., Yancy C.W., Bonow R.O., Gheorghiade M. Is hospital admission for heart failure really necessary? The role of the emergency department and observation unit in preventing hospitalization and rehospitalization. J Am Coll Cardiol 2013, 61:121-126.
12. Collins S., Hiestand B. Confounded by hospitalization: risk stratification and admission decisions in emergency department patients with acute heart failure. Acad Emerg Med 2013, 20:106-107.
13. Lee D.S., Stitt A., Austin P.C., et al. Prediction of heart failure mortality in emergent care: a cohort study. Ann Intern Med 2012, 156:767-775.
14. Auble T.E., Hsieh M., Gardner W., et al. A prediction rule to identify low-risk patients with heart failure. Acad Emerg Med 2005, 12:514-521.
15. Hsieh M., Auble T.E., Yealy D.M. Validation of the acute heart failure index. Ann Emerg Med 2008, 51:37-44.
16. Auble T.E., Hsieh M., McCausland J.B., Yealy D.M. Comparison of four clinical prediction rules for estimating risk in heart failure. Ann Emerg Med 2007, 50:127-135.
17. McCausland J.B., Machi M.S., Yealy D.M. Emergency physicians' risk attitudes in acute decompensated heart failure patients. Acad Emerg Med 2010, 17:108-110.
18. Peacock W.F., De Marco T., Fonarow G.C., et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008, 358:2117-2126.
19. Metra M., Cotter G., Davison B.A., et al. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol 2013, 61:196-206.
20. Kociol R.D., Pang P.S., Gheorghiade M., Fonarow G.C., O'Connor C.M., Felker G.M. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 2010, 56:1071-1078.
21. Pascual-Figal D.A., Casas T., Ordonez-Llanos J., et al. Highly sensitive troponin T for risk stratification of acutely destabilized heart failure. Am Heart J 2012, 163:1002-1010.
22. Felker G.M., Mentz R.J., Teerlink J., et al. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study. Eur J Heart Fail 2015, 17:1262-1270.
23. O'Connor C.M., Fiuzat M., Lombardi C., et al. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. Circ Heart Fail 2011, 4:724-732.
24. Teerlink J.R., Cotter G., Davison B.A., et al. Serelaxin, Recombinant Human Relaxin-2, for Treatment of Acute Heart Failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 2013, 381:29-39.
25. Ponikowski P., Metra M., Teerlink J.R., et al. Design of the Relaxin in Acute Heart Failure study. Am Heart J 2012, 163:149-155.
26. Voors A.A., Davison B.A., Teerlink J.R., et al. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome-an analysis from RELAX-AHF. Eur J Heart Fail 2014, 16:1230-1240.
27. Felker G.M., Hasselblad V., Tang W.H., et al. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. Eur J Heart Fail 2012, 14:1257-1264.
28. Shah A.S., Anand A., Sandoval Y., et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 2015, 386:2481-2488.
29. Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013, 62:1495-1539.
30. Krumholz H.M., Lin Z., Keenan P.S., et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA 2013, 309:587-593.
31. Setoguchi S., Stevenson L.W., Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 2007, 154:260-266.
32. Solomon S.D., Dobson J., Pocock S., et al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 2007, 116:1482-1487.
33. ADHERE Scientific Advisory Committee. Acute Decompensated Heart Failure National Registry (ADHERE®) Core Module Q1 2006 Final Cumulative National Benchmark Report 2006, Johnson & Johnson, New Brunswick, New Jersey.
34. Mozaffarian D., Benjamin E.J., Go A.S., et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015, 131:e29-e322.
35. Fonarow G.C., Adams K.F., Abraham W.T., Yancy C.W., Boscardin W.J., for the Adhere Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005, 293:572-580.
36. Meijers W.C., de Boer R.A., van Veldhuisen D.J., et al. Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH. Eur J Heart Fail 2015, 17:1271-1282.